-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Hims & Hers Health, Lowers Price Target to $32

Benzinga·11/10/2026 10:41:11
Needham analyst Ryan MacDonald maintains Hims & Hers Health (NYSE:HIMS) with a Buy and lowers the price target from $42 to $32.